February 21, 2025 · Form 4 insider transaction
Maizel Ari bought 7,816 shares of Axsome Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
The option will vest in substantially equal quarterly installments over four years such that the option will be fully vested on February 21, 2029.